Journal Pricing Sales Study 
Xconomy
MARCH 17, 2017
Stung by slow sales of its next-generation anti-cholesterol drug, Amgen hopes new clinical data, released this morning, will spur doctors to boost prescriptions and—perhaps more important—drive insurers to loosen their restrictions. political issue, and pricey new cholesterol drugs have been a key battleground.
InfoChachkie
JUNE 15, 2015
A version of this article previously appeared in the Wall Street Journal. For instance, if the team assumes that a higher price will result in a lower number of customers, it will have a tendency to recall those instances when a customer cancels due to price. Despite the 50% price increase, our sales exploded.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
JULY 8, 2016
British medical journal The Lancet published a study , funded by the Bill and Melinda Gates Foundation, that showed viral hepatitis has become the seventh leading cause of death globally, up from tenth in 1990. The FDA has halted the trial , and Juno’s share price dropped 28 percent after hours on Thursday.
Xconomy
AUGUST 19, 2016
. —The FDA last summer approved two new cholesterol fighting drugs known as PCSK9 inhibitors, but so far the market has rejected them, resulting in paltry sales. Everyone is waiting until 2017, when huge studies of the drugs’ ability to prevent heart attacks and strokes start to provide data.
Tech Zulu Event
APRIL 10, 2012
Things you don’t read about in the Wall St Journal. The craziest part is that studies have started to show that users who download an app for free are likely to spend more than $0.99 App prices change all of the time. Doesn’t it seem like its every person you see has an iPhone? Why not right? Distribution is everything.
Both Sides of the Table
AUGUST 30, 2010
This post was originally published in a shorter (more sensible) format in the Wall Street Journal online. The prices of angel deals have recently crept up, VCs have also gotten their checkbooks out again, frothy deals are happening and people are feeling bullish. We took $2.3 between June and July 2010 (and 25% from a year ago).
Expert insights. Personalized for you.
87 
Let's personalize your content